RONALD BYRD: Open Payments
NPI 1336396415 · SNOWFLAKE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 13 payments from 8 companies in 2025. Trend: 2023 $67 · 2024 $164 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Novo Nordisk Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Krystal Biotech Inc | 1 | $18 |
| Verona Pharma, Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, AUSTEDO XR, AIRSUPRA, KISUNLA, Rybelsus, GVOKE HYPOPEN, VYJUVEK, Ohtuvayre.
Industry payments across AZ — which companies pay providers there.
